🍽🦠 PubMed Studies Citing Bacteria Shifts for Metha family {Mint} - Bacillus subtilis subsp. amylosacchariticus

Citations are updated once a week. Recently added citations may not appear.

4 Citations Found, Full List Requires Login Summary Publisher Link Html Article Download Article Why do I only have some/no links buttons showing?
πŸ““ - Direct Citation   |   πŸ‘ͺ - Infer Parent  |   πŸ‘Ά - Infer Child |   βš—οΈ - Inferred from bacteria association
For Samples: 😁 - Shifts in right direction   |   😒 - Shifts in wrong direction
Context Citation
Metha family {Mint} - Bacillus subtilis subsp. amylosacchariticus    👶 Biocomposites of Silk-Elastin and Essential Oil from Mentha piperita Display Antibacterial Activity.
ACS omega (ACS Omega ) Vol: 7 Issue 8 Pages: 6568-6578
Pub: 2022 Mar 1 Epub: 2022 Feb 15 Authors Gomes DS , da Costa A , Pereira AM , Casal M , Machado R ,
Html Article Publication
Metha family {Mint} - Bacillus subtilis subsp. amylosacchariticus    👶 Evaluation of Phenolic Compounds and Antioxidant and Antimicrobial Activities of Some Common Herbs.
International journal of analytical chemistry (Int J Anal Chem ) Vol: 2017 Issue Pages: 3475738
Pub: 2017 Epub: 2017 Feb 16 Authors Abdul Qadir M , Shahzadi SK , Bashir A , Munir A , Shahzad S ,
Html Article Publication
Metha family {Mint} - Bacillus subtilis subsp. amylosacchariticus    👶 Inhibitory effects of spice essential oils on the growth of Bacillus species.
Journal of medicinal food (J Med Food ) Vol: 9 Issue 3 Pages: 418-21
Pub: 2006 Fall Epub: Authors Ozcan MM , Sagdiç O , Ozkan G ,
Publication
Metha family {Mint} - Bacillus subtilis subsp. amylosacchariticus    👶 Nutritionally rich biochemical profile in essential oil of various Mentha species and their antimicrobial activities.
Protoplasma (Protoplasma ) Vol: 260 Issue 2 Pages: 557-570
Pub: 2023 Mar Epub: 2022 Aug 9 Authors Fazal H , Akram M , Ahmad N , Qaisar M , Kanwal F , Rehman G , Ullah I ,
Publication

BOOM

All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.

Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.


The awesome web hosting site that we use. Try it if you need to host (or unhappy with current provider)